SDS Biotech K.K. Reports Consolidated and Non-Consolidated Earnings Results for the Year Ended March 31, 2017; Announces Dividend for the Year Ended March 31, 2017, Payable on June 29, 2017; Provides Earnings Guidance for the Year Ending March 31, 2018; Provides Dividend Guidance for the Second Quarter and Fiscal Year 2018
For the fiscal year 2017, the company announced dividend of ¥12.50 per share compared to ¥15.00 per share paid in last year.
For the second quarter of fiscal year 2018, the company expected to pay dividend of ¥12.50 per share.
For the fiscal year 2018, the company expected to pay dividend of ¥12.50 per share.
The company provided earnings guidance for the year ending March 31, 2018. For the year, the company expected net sales of ¥15,860 million, operating income of ¥1,440 million, ordinary income of ¥1,320 million, net income attributable to owners of parent of ¥630 million or ¥80.45 per share.
For the year, the non-consolidated company reported net sales of ¥12,491 million compared to ¥16,534 million, operating income of ¥1,263 million compared to ¥2,410 million, ordinary income of ¥1,316 million compared to ¥2,398 million, net loss attributable to owners of parent of ¥768 million or ¥98.16 per share compared to net income attributable to owners of parent of ¥1,608 million ¥205.42 per share for the last year.